KFDA to simplify licensing conditions of OTCs, quasi-drugs

Published: 2010-07-26 06:58:00

Updated: 2010-07-26 06:58:00

Drug manufacturers and quasi-drug makers using 40 standard substances formulation, including herbs and ibuprofen, will be able to market their products with notification only, the Korea Food and Drug Administration on July 21.

The 40 standard substances refer to those whose safety and efficacy...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK